Skip to main content
Mallory
CriticalExploited in the wildCISA KEVVulnerability

CVE-2026-123218: Authorization Bypass and Administrative Privilege Escalation in IBM Aspera Faspex

Published Nov 7, 2026 · Updated 2 days ago
Trending this week#92of 427,828 vulnerabilities
Mention activity · 30 days80 mentions · peak 34 in a dayToday
CVSS9.8Critical · v3.1
EPSS0.53%46th percentile
CISA KEVYesAdded Nov 9, 2026
In the wildActivePer CISA KEV
Vendor
International Business Machines
IdentifiersCVE-2026-123218CWE-863 · Incorrect Authorization

CVE-2026-123218 is an incorrect authorization vulnerability in IBM Aspera Faspex versions 5.0.0 through 5.0.19. An authenticated user can submit a specially crafted message that bypasses application authorization checks and grants full Faspex administrative privileges. The affected endpoint, message fields, and vulnerable function have not been identified publicly. The vulnerability is fixed in version 5.0.19 PL1.

Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Analyst brief

Impact, mitigation & remediation

What it means and what to do now: patch path, interim mitigations, and the assume-compromise checklist.

Impact

What an attacker gets, and what they’ve been doing with it.

Successful exploitation compromises application-level access controls, allowing an authenticated user to obtain full Faspex administrative privileges. This can expose sensitive information and permit unauthorized modification of application configuration or disruption of service, with potentially high confidentiality, integrity, and availability impacts. Operating system command execution and root access to the underlying host are not established.

Mitigation

If you can’t patch tonight, do this now.

IBM lists no vendor-approved workarounds or alternative mitigations. Until patching is completed, restrict access to affected deployments to trusted users and monitor for unexpected administrative privilege changes. These precautions do not correct the authorization flaw or replace the update.

Remediation

Patch, then assume compromise.

Upgrade affected deployments to IBM Aspera Faspex 5.0.19 PL1 or a later vendor-confirmed fixed release using IBM's installation instructions. Verify that the running faspex-core container reports version 5.0.19, build identifier 1ce4b13, and Fix Pack 1 when installing PL1. Checking the main version number alone is insufficient because vulnerable and corrected releases both report 5.0.19. Perform forensic triage for possible prior compromise alongside remediation.

Public exploits

Exploits

No validated public exploits yet. Hidden: 1 rejected by Mallory's analysis as not a working exploit.

View more in app →
Every candidate exploit was rejected by Mallory's analysis.
Exposure surface

Affected products & vendors

Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.

VendorProductType
International Business MachinesAspera Faspexapplication
FAQ

Frequently asked questions

Is CVE-2026-123218 exploited in the wild?
Yes. As of Nov 15, 2026, Mallory has reports of exploitation in the wild, and CISA added it to KEV on Nov 9, 2026.
Is there a public exploit for CVE-2026-123218?
As of Nov 15, 2026, Mallory has found no public exploit for CVE-2026-123218.
Is there a patch for CVE-2026-123218?
Upgrade affected deployments to IBM Aspera Faspex 5.0.19 PL1 or a later vendor-confirmed fixed release using IBM's installation instructions. Verify that the running faspex-core container reports version 5.0.19, build identifier 1ce4b13, and Fix Pack 1 when installing PL1.
What products are affected by CVE-2026-123218?
International Business Machines Aspera Faspex.
How severe is CVE-2026-123218?
CVE-2026-123218 has a CVSS v3.1 score of 9.8 (Critical) and an EPSS score of 0.53% (46th percentile) as of Nov 15, 2026.
Activity feed

Recent activity

80 sources tracked across advisories, community write-ups, and news. New activity surfaces here as Mallory finds it.

View more in app →
cameroon cirtNews · Nov 15, 2026[CRITIQUE] Campagnes actives contre Barracuda et Chromium - CIRTThe alert identifies a vulnerability affecting an unspecified IBM product and states that vendor patches are available. It reports active exploitation and CISA KEV inclusion but does not describe the vulnerability mechanism, impact, or affected versions. These claims are not independently verified by the supplied content.Read more ↗csirt italiaNews · Nov 13, 2026IBM: rilvato sfruttamento attivo in rete della CVE-2026-123218 - ACNAn incorrect authorization vulnerability in IBM Aspera Faspex allows an authenticated attacker to bypass application access controls using specially crafted messages and obtain full administrative privileges. The notice assigns a CVSS v3.1 score of 9.8 and reports active exploitation.Read more ↗csirt italiaNews · Nov 13, 2026IBM: rilevato sfruttamento attivo in rete della CVE-2026-123218 - ACNAn incorrect authorization vulnerability in IBM Aspera Faspex 5.0.x through version 5.0.19 allows an authenticated attacker to send specially crafted messages, bypass access controls, and obtain full administrative privileges. The content reports a CVSS v3.1 score of 9.8, active exploitation, and an available vendor fix.Read more ↗security affairsNews · Nov 10, 2026U.S. CISA adds IBM, SignalWire FreeSwitch, OpenSSH, and GPUStack flaws to its Known Exploited Vulnerabilities catalogAn incorrect authorization vulnerability with a CVSS score of 9.8 affecting IBM Aspera Faspex versions 5.0.0 through 5.0.19. An authenticated user can craft a message that bypasses authorization checks and potentially grants full administrative privileges, enabling access to sensitive information and modification or disruption of the system. Exploitation status is ambiguous because the article reports KEV inclusion while also stating that public confirmation was not found.Read more ↗
+11 more in the timeline. Sign up to see them
Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Mallory platform

The version that knows your environment.

This page is what’s public. Mallory adds the parts that aren’t: which of your assets are affected, which adversaries are exploiting it right now, and which detections to deploy tonight.
Exposure mappingQuery your assets running an affected version, and investigate the blast radius.
Threat actor evidenceEvery report linking this CVE to a named adversary.
Associated malwareMalware families linked to this CVE, with evidence and IOCs.
Detection signatures1YARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Vendor-by-vendor mappingCross-references every affected SKU, including bundled OEM variants.
Social activity62Community discussion across Reddit, Mastodon, and other social sources.